Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets (Details)

v3.24.3
Schedule of Deferred Tax Assets (Details) - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 3,738,702 $ 2,866,860
Other assets and liabilities 226,530 272,162
Stock- based compensation 457,501 298,135
Capitalized research and development expenditures 1,985,585 1,248,760
Gross deferred tax assets 6,408,318 4,685,917
Valuation allowance (6,408,318) (4,685,917)
Total deferred tax assets, net of valuation allowance